#AcuteHepaticPorphyria
LightNews LightNews
hemehub.bsky.social
🌟Today’s questions!

Swipe to see the answers and explanations!

#AIP #AcuteHepaticPorphyria #Afamelanotide #EPP #Porphyria #Hematology #HemeOnc #MedEd #HemeHub
November 1, 2026 at 5:06 AM
hemehub.bsky.social
🩸 Facts about Acute Hepatic Porphyria:

Givosiran-associated pancreatitis and postmarketing safety signals, hemin treatment risks, ALAS1 suppression, breakthrough attacks during therapy, and HCC risk and surveillance.

#AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hemin #Hematology #HemeOnc
October 26, 2026 at 10:34 PM
hemehub.bsky.social
🎯Today’s questions!

Swipe to see the answers and explanations!

#HemeHub #Hematology #HemeOnc #AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hepatocytes #MedEd #EPP #Porphyria #Afamelanotide #Bitopertin #GlyT1
October 26, 2026 at 10:35 PM
hemehub.bsky.social
🔎🌟Today’s questions!

Swipe to see the answers and explanations!

#HemeHub #Hematology #HemeOnc #AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hepatocytes #MedEd
October 21, 2026 at 7:50 PM
hemehub.bsky.social
🩸Facts about Acute Hepatic Porphyria:

Hyperhomocysteinemia during givosiran treatment, vitamin B6 supplementation, and givosiran-associated pancreatitis, including safety signals and time-to-onset.

#AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hematology #HemeOnc #MedEd #HemeHub
October 21, 2026 at 7:49 PM
hemehub.bsky.social
💡🚀Today’s questions!

Swipe to see the answers and explanations!

#AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hematology #HemeOnc #MedicalEducation #MedEd #HemeHub
October 18, 2026 at 4:27 AM
hemehub.bsky.social
🩸 Facts about Acute Hepatic Porphyria:

Givosiran treatment, long-term outcomes, common side effects, liver enzyme elevations, and hyperhomocysteinemia.

#AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hematology #HemeOnc #MedicalEducation #MedEd #HemeHub
October 18, 2026 at 4:26 AM
hemehub.bsky.social
🚀💡Today’s questions!

Swipe to see the answers and explanations!

#HemeHub #Hematology #HemeOnc #AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hyperhomocysteinemia #VitaminB6 #MedEd
October 16, 2026 at 2:34 AM
hemehub.bsky.social
🩸 Facts about Acute Hepatic Porphyria:

Heme synthesis, the role of the liver in AHP, how givosiran works, and its effectiveness in reducing acute attacks.

#AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hematology #HemeOnc #MedicalEducation #MedEd #HemeHub
October 16, 2026 at 2:33 AM
hemehub.bsky.social
🩸 Facts about Acute Hepatic Porphyria:

The four types of AHP, the role of ALAS1 in heme synthesis, the buildup of neurotoxic ALA and PBG, and common triggers of acute attacks, including fasting, alcohol, stress, and certain medications.

#AHP #AcuteHepaticPorphyria #Porphyria #Hematology #HemeOnc
October 13, 2026 at 2:58 AM
hemehub.bsky.social
🩸 This Month on HemeHub: Acute Hepatic Porphyria

Explore diagnosis, acute attacks, common triggers, and treatments including IV hemin and givosiran.

🌐 Learn more: hemehub.org

#AcuteHepaticPorphyria #Porphyria #Hematology #HemeHub
October 11, 2026 at 3:30 AM
gastroadvisor.bsky.social
Watch our new video interview from #DDW2026 with Brendan McGuire, MD, about hallmark clinical features of #acutehepaticporphyria, diagnostic delays, unnecessary operations, and more:
https://www.gastroenterologyadvisor.com/reports/video-recurrent-abdominal-pain-in-women-acute-hepatic-porphyria/
Video: Recurrent Abdominal Pain in Women May Signal Acute Hepatic Porphyria
Brendan McGuire, MD, discusses how to recognize acute hepatic porphyria, key diagnostic tests, and current treatment approaches.
www.gastroenterologyadvisor.com
May 16, 2026 at 7:33 PM